These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 15144930)

  • 1. beta-Blockers in hypertension: is carvedilol different?
    Messerli FH; Grossman E
    Am J Cardiol; 2004 May; 93(9A):7B-12B. PubMed ID: 15144930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasodilating versus first-generation β-blockers for cardiovascular protection.
    Fares H; Lavie CJ; Ventura HO
    Postgrad Med; 2012 Mar; 124(2):7-15. PubMed ID: 22437211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carvedilol in hypertension treatment.
    Stafylas PC; Sarafidis PA
    Vasc Health Risk Manag; 2008; 4(1):23-30. PubMed ID: 18629377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of 2 beta-receptor blocking agents on the microcirculation of healthy subjects and of hypertensive patients.
    Albrecht M; Haustein KO
    Int J Clin Pharmacol Ther; 1997 Dec; 35(12):580-6. PubMed ID: 9455718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of carvedilol on the hemodynamics and its tolerance in elderly patients].
    Asai T; Kuzuya M; Koike A; Kanda S; Maeda K; Iguchi A
    Nihon Ronen Igakkai Zasshi; 2002 Mar; 39(2):187-92. PubMed ID: 11974943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of salt intake on the antihypertensive effect of carvedilol.
    Ruilope LM; Lahera V
    J Hypertens Suppl; 1993 Jun; 11(4):S17-9. PubMed ID: 8104238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An in-depth analysis of vasodilation in the management of hypertension: focus on adrenergic blockade.
    Bakris G
    J Cardiovasc Pharmacol; 2009 May; 53(5):379-87. PubMed ID: 19454898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Carvedilol].
    Antepohl W; Herzig S; Böhm M
    Dtsch Med Wochenschr; 1997 Jun; 122(25-26):833-4. PubMed ID: 9244672
    [No Abstract]   [Full Text] [Related]  

  • 9. Chronic carvedilol reduces mortality and renal damage in hypertensive stroke-prone rats.
    Barone FC; Nelson AH; Ohlstein EH; Willette RN; Sealey JE; Laragh JH; Campbell WG; Feuerstein GZ
    J Pharmacol Exp Ther; 1996 Nov; 279(2):948-55. PubMed ID: 8930204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β-blockers: a review of their pharmacological and physiological diversity in hypertension.
    Ripley TL; Saseen JJ
    Ann Pharmacother; 2014 Jun; 48(6):723-33. PubMed ID: 24687542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Appropriate dose transition to a controlled-release formulation of carvedilol in patients with hypertension.
    Bakris GL; Weber MA
    Rev Cardiovasc Med; 2008; 9(2):96-105. PubMed ID: 18660730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Body weight changes with beta-blocker use: results from GEMINI.
    Messerli FH; Bell DS; Fonseca V; Katholi RE; McGill JB; Phillips RA; Raskin P; Wright JT; Bangalore S; Holdbrook FK; Lukas MA; Anderson KM; Bakris GL;
    Am J Med; 2007 Jul; 120(7):610-5. PubMed ID: 17602935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carvedilol in hypertension: effects on hemodynamics and 24-hour blood pressure.
    Lund-Johansen P; Omvik P; Nordrehaug JE; White W
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S27-34. PubMed ID: 1378146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The vasodilatory beta-blockers.
    Pedersen ME; Cockcroft JR
    Curr Hypertens Rep; 2007 Aug; 9(4):269-77. PubMed ID: 17686376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective versus nonselective beta-adrenergic receptor blockade in chronic heart failure: differential effects on myocardial energy substrate utilization.
    Al-Hesayen A; Azevedo ER; Floras JS; Hollingshead S; Lopaschuk GD; Parker JD
    Eur J Heart Fail; 2005 Jun; 7(4):618-23. PubMed ID: 15921803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antihypertensive activity and effect on parameters of heart rate variability of beta-blockers carvedilol and metoprolol].
    Praskurnichiĭ EA; Shevchenko OP; Makarova SV; Zhukova VA
    Kardiologiia; 2005; 45(11):17-23. PubMed ID: 16353059
    [No Abstract]   [Full Text] [Related]  

  • 17. What is the role, if any, for beta-blockers as initial therapy for uncomplicated hypertension?
    Pedersen ME; Cockcroft JR
    Curr Opin Cardiol; 2009 Jul; 24(4):325-32. PubMed ID: 19417638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carvedilol.
    Frishman WH
    N Engl J Med; 1998 Dec; 339(24):1759-65. PubMed ID: 9845712
    [No Abstract]   [Full Text] [Related]  

  • 19. Carvedilol: something else than a simple betablocker?
    Palazzuoli A; Calabria P; Verzuri MS; Auteri A
    Eur Rev Med Pharmacol Sci; 2002; 6(6):115-26. PubMed ID: 12776805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of carvedilol and metoprolol on blood pressure, blood flow, and vascular resistance.
    Morgan T; Snowden R; Butcher L
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S124-9. PubMed ID: 2454358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.